TERPS Trial for de Novo Oligometastic Prostate Cancer
Status:
Not yet recruiting
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
This research is being done to determine if we can improve the outcome of prostate cancer
patients who have failed primary treatment - surgery or local radiation to the prostate - and
have three or fewer bone or soft tissue metastases.